JP2016518424A - ヘルペス処置のための薬剤と方法 - Google Patents

ヘルペス処置のための薬剤と方法 Download PDF

Info

Publication number
JP2016518424A
JP2016518424A JP2016513342A JP2016513342A JP2016518424A JP 2016518424 A JP2016518424 A JP 2016518424A JP 2016513342 A JP2016513342 A JP 2016513342A JP 2016513342 A JP2016513342 A JP 2016513342A JP 2016518424 A JP2016518424 A JP 2016518424A
Authority
JP
Japan
Prior art keywords
composition
weight
herpes
methylpropanol
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016513342A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016518424A5 (cg-RX-API-DMAC10.html
Inventor
ナディネ・ハイザー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Najopharm GmbH
Original Assignee
Najopharm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Najopharm GmbH filed Critical Najopharm GmbH
Publication of JP2016518424A publication Critical patent/JP2016518424A/ja
Publication of JP2016518424A5 publication Critical patent/JP2016518424A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2016513342A 2013-05-14 2014-05-14 ヘルペス処置のための薬剤と方法 Pending JP2016518424A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13167597.7A EP2803354B1 (de) 2013-05-14 2013-05-14 Kombination aus Polyacrylsäure und 2-Amino-2-methylpropanol zur Verwendung in der Behandlung von Herpesinfektionen
EP13167597.7 2013-05-14
PCT/EP2014/059813 WO2014184223A1 (de) 2013-05-14 2014-05-14 Mittel und verfahren zur behandlung von herpes

Publications (2)

Publication Number Publication Date
JP2016518424A true JP2016518424A (ja) 2016-06-23
JP2016518424A5 JP2016518424A5 (cg-RX-API-DMAC10.html) 2017-04-27

Family

ID=48366229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016513342A Pending JP2016518424A (ja) 2013-05-14 2014-05-14 ヘルペス処置のための薬剤と方法

Country Status (7)

Country Link
US (1) US20160166603A1 (cg-RX-API-DMAC10.html)
EP (1) EP2803354B1 (cg-RX-API-DMAC10.html)
JP (1) JP2016518424A (cg-RX-API-DMAC10.html)
AU (1) AU2014267349A1 (cg-RX-API-DMAC10.html)
BR (1) BR112015028334A2 (cg-RX-API-DMAC10.html)
ES (1) ES2538335T3 (cg-RX-API-DMAC10.html)
WO (1) WO2014184223A1 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017212422A1 (en) * 2016-06-08 2017-12-14 Novartis Consumer Health Sa Topical compositions comprising carbomer for the treatment and prevention of viral infections and allergic conditions
US20210330700A1 (en) * 2020-04-23 2021-10-28 Johnson & Johnson Consumer Inc. Methods and compositions for inhibiting influenza viruses using low molecular weight hydrophobically modified polymers and polyalkylene glycols
DE102025101480A1 (de) 2025-01-16 2026-07-16 Pigmentsolution GmbH Konservierungszusammensetzung
DE202026100173U1 (de) 2025-01-16 2026-05-28 Pigmentsolution GmbH Rohr-im-Rohr-Homogenisierer
EP4778390A3 (de) 2025-01-16 2026-08-12 Pigmentsolution GmbH Konservierungszusammensetzung

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6251617A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd ビダラビンゲル軟膏
JPS62263111A (ja) * 1986-05-09 1987-11-16 Shiseido Co Ltd 粘性組成物
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
JPH08143460A (ja) * 1994-11-17 1996-06-04 Haruhito Miyata 水虫類の治療方法及び用材
JPH11511180A (ja) * 1996-06-12 1999-09-28 ストア ソシエテ アノニマ 化粧品のための物理的殺菌用ゲル
JP2004505906A (ja) * 2000-08-09 2004-02-26 フアーマシア アクチエボラグ ミノキシジルの新規組成物
WO2004069261A1 (ja) * 2003-02-03 2004-08-19 Arigen, Inc. 抗ヘルペスウイルス外用製剤の製造方法
JP2005263695A (ja) * 2004-03-18 2005-09-29 Suiko Giken Kk 水虫治療薬
JP2008533052A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 抗ウイルス性組成物および使用方法
JP2011030981A (ja) * 2009-08-06 2011-02-17 Dainippon Printing Co Ltd 皮膚貼付用組成物および皮膚貼付用材
JP2012525416A (ja) * 2009-04-28 2012-10-22 オールトランツ インコーポレイティド カンナビジオールの製剤及びその使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2174242A (en) 1937-08-13 1939-09-26 Purdue Research Foundation Aminoglycols
US5622690A (en) * 1990-04-05 1997-04-22 Nurture, Inc. Seed-derived proteinaceous compositions for reduction of sunburn cell formation
US8267927B2 (en) * 2007-01-24 2012-09-18 Koninklijke Philips Electronics N.V. Advanced ablation planning
IT1395137B1 (it) * 2009-08-05 2012-09-05 Spider Biotech S R L Nuovi peptidi antipatogeni
WO2012004669A1 (en) * 2010-07-08 2012-01-12 Devirex Ag Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster
US20130072575A1 (en) * 2011-09-19 2013-03-21 Johnson & Johnson Consumer Companies, Inc. Method and Composition for Treating Pain

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6251617A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd ビダラビンゲル軟膏
JPS62263111A (ja) * 1986-05-09 1987-11-16 Shiseido Co Ltd 粘性組成物
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
JPH08143460A (ja) * 1994-11-17 1996-06-04 Haruhito Miyata 水虫類の治療方法及び用材
JPH11511180A (ja) * 1996-06-12 1999-09-28 ストア ソシエテ アノニマ 化粧品のための物理的殺菌用ゲル
JP2004505906A (ja) * 2000-08-09 2004-02-26 フアーマシア アクチエボラグ ミノキシジルの新規組成物
WO2004069261A1 (ja) * 2003-02-03 2004-08-19 Arigen, Inc. 抗ヘルペスウイルス外用製剤の製造方法
JP2005263695A (ja) * 2004-03-18 2005-09-29 Suiko Giken Kk 水虫治療薬
JP2008533052A (ja) * 2005-03-10 2008-08-21 スリーエム イノベイティブ プロパティズ カンパニー 抗ウイルス性組成物および使用方法
JP2012525416A (ja) * 2009-04-28 2012-10-22 オールトランツ インコーポレイティド カンナビジオールの製剤及びその使用方法
JP2011030981A (ja) * 2009-08-06 2011-02-17 Dainippon Printing Co Ltd 皮膚貼付用組成物および皮膚貼付用材

Also Published As

Publication number Publication date
BR112015028334A2 (pt) 2017-07-25
EP2803354A1 (de) 2014-11-19
WO2014184223A1 (de) 2014-11-20
ES2538335T3 (es) 2015-06-19
EP2803354B1 (de) 2015-03-04
US20160166603A1 (en) 2016-06-16
AU2014267349A1 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
CN101801414B (zh) 口腔用和皮肤用组合物
US20110064826A1 (en) Composition for treating skin lesions
US20090220440A1 (en) Spray Composition for Topical Use for Treating and/or Preventing Herpes Simplex Labial Infections
ES2538335T3 (es) Combinación de ácido poliacrílico y 2-amino-2-metilpropanol para uso en el tratamiento de infecciones por herpes
Agnihotri et al. Oral ulceration and Indian herbs: a scoping review
WO2011069184A1 (en) Composition for treating skin lesions
DK2343038T3 (en) Dermatological compositions containing a combination of peroxidized lipids and zinc and their use, especially for the treatment of herpes
JP2008543885A (ja) 皮膚病変治療用組成物
WO2016181355A1 (en) Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity
JP2012193159A (ja) 鼻用スプレー
ES2678122T3 (es) Comprimidos bucales mucoadherentes para el tratamiento del herpes orofacial
US20170020946A1 (en) Analgesic compositions and methods of use
WO2015072853A1 (en) Treatment of herpes virus infection outbreaks
US9901555B2 (en) Treatment of viral infections
CN103153312A (zh) 用于预防性治疗和治疗性治疗疱疹感染的吡罗昔康
WO2011057363A1 (en) Disposable device and uses thereof for skin and mucosal applications
Zakaria et al. Comparing pomegranate extract and chlorhexidine mouthwashes in treatment of recurrent intraoral herpes
RU2147440C1 (ru) Обезболивающее и противозудное средство
EP4731182A1 (en) Topical regimen for treating cold sores
CN110464673A (zh) 一种口腔正畸用护理组合物及其制备方法
JP2009542703A (ja) 口唇ヘルペス(単純疱疹)の局所治療のための抗ウイルス組成物およびそれを用いる方法
JP2000355543A (ja) アスピリンを主成分とする爪白癬症用外用治療剤
JP2015078162A (ja) 過活動膀胱を治療および/または予防するための医薬組成物
NZ614958B2 (en) The treatment of viral infections

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170323

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20171205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180302

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180731

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20190305